Funding for this research was provided by:
National Natural Science Foundation of China (81472240, 8177110562, 81802911)
Science and Technology Commission of Shanghai Municipality (16411952700, 10411955400, 09411960800)
Shanghai Shen Kang Hospital Development Center (16CR3028A, 16CR2002A)
Shanghai Outstanding Academic Leaders Plan (2016)
Received: 25 March 2019
Accepted: 27 May 2019
First Online: 10 June 2019
Ethics approval and consent to participate
: This study was preceded in accordance with the standards of Institute Research Ethics Committee of Renji Hospital Hospital, and written informed consent to participate in this study was obtained from GBC patients and cholecystolithiasis patients.
: All authors have agreed to publish this manuscript.
: The authors declare that they have no competing interests.